Vitamin C inhibits p53-induced replicative senescence through suppression of ROS production and p38 MAPK activity

Area of Science:

• Cell Biology
• Biochemistry
• Cancer Research

Background:

• Tumor cells expressing p53 elevate intracellular reactive oxygen species (ROS).
• Replicative senescence is a process linked to cell cycle arrest and aging.
• Understanding senescence inhibition is crucial for cancer therapy.

Purpose of the Study:

• To investigate the inhibitory effect of vitamin C on p53-induced replicative senescence.
• To elucidate the molecular mechanisms underlying vitamin C's action.
• To determine the role of ROS and p38 kinase in this process.

Main Methods:

• Treatment of human bladder cancer EJ cells with vitamin C.
• Analysis of senescence-like phenotype (SLP), cell cycle arrest, and ROS generation.
• Investigation of p38 kinase activation using chemical inhibitors (SB203580).

Main Results:

• Vitamin C inhibited p53-induced senescence and ROS generation in EJ cells.
• The senescence-like phenotype and irreversible cell cycle arrest were prevented by vitamin C.
• p38 kinase activation, observed during p53-induced senescence, was inhibited by vitamin C.
• SB203580, a p38 kinase inhibitor, also inhibited p53-induced senescence.

Conclusions:

• Vitamin C inhibits p53-induced senescence by blocking ROS generation.
• This inhibition is mediated through the p38 MAPKinase pathway.
• Vitamin C represents a potential therapeutic agent for modulating cellular senescence in cancer.